TREVISAN ROBERTO

Ruolo: 
Professore associato
Settore scientifico disciplinare: 
ENDOCRINOLOGIA (MED/13)

Pubblicazioni

  • Penno, G., Solini, A., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., et al. (2021). Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study. BMC MEDICINE, 19(1). Dettaglio
  • Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021). Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. DIGESTIVE AND LIVER DISEASE, 53(7 (JUL 2021)), 866-872 [10.1016/j.dld.2021.02.010]. Dettaglio
  • Ruggenenti, P., Cortinovis, M., Parvanova, A., Trillini, M., Iliev, I., Bossi, A., et al. (2021). Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study. PLOS MEDICINE, 18(7) [10.1371/journal.pmed.1003691]. Dettaglio
  • Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021). Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease. AMERICAN JOURNAL OF NEPHROLOGY, 52(8), 666-672 [10.1159/000518111]. Dettaglio
  • Ciardullo, S., Trevisan, R., & Perseghin, G. (2021). Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines. PHARMACOLOGICAL RESEARCH, 166(April 2021) [10.1016/j.phrs.2021.105530]. Dettaglio